Abstract

Developing multimodal contrast agents is an upcoming area and hydroxyapatite nanoparticles substituted with various elements like gadolinium, eurobium etc., seems to be a promising contrast agent, especially for multimodal imaging of bone-tissue interface. A bimodal contrast agent using silver (Ag+) and gadolinium (Gd3+) ions co-substituted hydroxyapatite nanoparticles has been developed for X-ray and magnetic resonance imaging. Ag+ and Gd3+ ions were co-substituted into hydroxyapatite at various atomic percentages (Ag:Gd=0.25:0.25, 0.25:0.5, 0.25:0.75) using microwave accelerated wet chemical synthesis. Pure as well as Ag+ and Gd3+ ions substituted hydroxyapatite samples were also synthesized for comparison. All samples were characterized by X-ray diffraction, Fourier transform infrared spectroscopy, transmission electron microscopy etc., and found to be monophasic, nanocrystalline with the substituted ions. These co-substituted hydroxyapatite samples were then tested in different diagnostic modalities such as X-ray, computed tomography imaging and magnetic resonance imaging. Appreciable variation in contrast was observed with different amount of substitutions. All the Ag+ and Gd3+ ions co-substituted hydroxyapatite nanoparticles showed higher contrast in all imaging modalities compared to those substituted with either Ag+ or Gd3+ ions only. Hydroxyapatite sample co-substituted with 0.25Ag and 0.75Gd at. % substitution showed the best bimodal CT-MRI contrast.

Highlights

  • Various non-invasive imaging modalities such as computed X-ray tomography (CT), magnetic resonance imaging (MRI), ultrasound imaging (USI), positron emission tomography (PET) and single photon emission spectroscopy (SPECT) are used in the diagnosis of various diseases [1,2]

  • A single imaging technique does not give a complete perspective on all aspects of a disease/disorder, it is common in clinical practice to rely on two or more techniques to arrive at an accurate and reliable diagnosis

  • Only separate contrast agents are used for each imaging mode like iodine or barium compounds as radio contrast agents for X-ray/CT imaging, paramagnetic Gd3+ compounds and super paramagnetic iron oxide (SPIO) nanoparticles for MR imaging [3]

Read more

Summary

Introduction

Various non-invasive imaging modalities such as computed X-ray tomography (CT), magnetic resonance imaging (MRI), ultrasound imaging (USI), positron emission tomography (PET) and single photon emission spectroscopy (SPECT) are used in the diagnosis of various diseases [1,2]. Studies are being carried out to combine different modes of imaging by developing a single contrast agent based on polymers, liposomes and inorganic nanoparticles like hydroxyapatite (HA) [3,4]. Multimodal contrast agents based on inorganic nanoparticles have attracted considerable attention due to their small tunable size and attractive physical and chemical properties including bio-functionalization, prolonged circulating half-life, passive accumulation at tumor site through enhanced permeation and retention (EPR) effect [5]. The nanoparticulate contrast agents have been reported to provide enhanced signal sensitivity and impart information at the cellular levels [7]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.